CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
CD79a surface staining: a useful marker of mature B cells - EXBIO Antibodies
Phospho-CD19 (Tyr531) Antibody | Cell Signaling Technology
Introduction to Flow Cytometric Analysis | Flow Cytometry
Flow cytometry analysis of B-cell antigenic surface markers B220 and... | Download Scientific Diagram
A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry - Pracht - 2017 - European Journal of Immunology - Wiley Online Library
Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications
BV421 Rat Anti-Mouse CD19
View Image
CD19 Antibody (Dako Omnis) | Agilent
RB780 Mouse Anti-Human CD19
International Clinical Cytometry Society
APC Anti-Mouse CD19 (1D3) | Cytek Biosciences
Figures and data in A dynamic interaction between CD19 and the tetraspanin CD81 controls B cell co-receptor trafficking | eLife
Unraveling B cell trajectories at single cell resolution: Trends in Immunology
A Guide to B Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
B Cells
CD19 PE
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus: Molecular Therapy - Methods & Clinical Development
Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
